Business Context and Reporting Period
This Form 6-K filing by British American Tobacco p.l.c. (BAT) is dated December 9, 2025. The report incorporates by reference a press release titled "On track for FY25 delivery; Reaffirming 2026 guidance and announcing a £1.3bn share buy-back." The filing confirms the company's status as a foreign private issuer filing under Form 20-F.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release containing these details but does not reproduce the specific figures within the body of this Form 6-K document.
Material Changes and Strategic Actions
- Share Buy-back: BAT announced a new share buy-back program totaling £1.3 billion.
- Performance Status: The company states it is "on track" for its Full Year 2025 (FY25) delivery targets.
- Guidance Reaffirmation: Management has reaffirmed its guidance for the 2026 fiscal year.
- Leverage Target: The company remains on track to reduce leverage to within a 2.0-2.5x range by the end of 2026.
Outlook, Management Commentary, and Risks
Management commentary indicates momentum continues in three key areas, though the specific details of these areas are excluded from the text of this filing. The outlook includes a reference to profitability being on-track for the full year and expectations of double-digit growth in the second half of the year. The filing includes standard forward-looking statement disclaimers but does not detail specific risks or contingencies in the provided text.
Investor Verification Checklist
- Verify the specific FY25 revenue and profit figures in the referenced Exhibit 1 press release.
- Confirm the detailed terms and timeline of the £1.3 billion share buy-back program.
- Review the specific 2026 guidance metrics (revenue, earnings, free cash flow) reaffirmed by management.
- Examine the "three key areas" of momentum mentioned in the outlook for further operational context.
- Check the latest leverage ratio to confirm progress toward the 2.0-2.5x target.